Today the conference "Dialogues on Clinical Research" kicked off. The section "International Cooperation in Clinical Research" was moderated by Dmitry Chagin (Corporation for the Development of St. Petersburg, Union "Medico-Pharmaceutical Projects") and Sergey Simeniv (X7 Research).
Sergey Simeniv spoke about how the Russian pharmaceutical industry is adapting to new realities, successfully transitioning to EAEU standards and continuing to develop despite sanctions. According to him, the key to success is an individual approach to each company's tasks, from production to obtaining data.
A large‑scale project in China, where a municipality and a leading medical university are creating a powerful center for clinical research, was presented by Murtazali Dibirov (project coordinator for the SCO). He emphasized that the ecosystem includes technology parks, startups, and the country's second largest pharmaceutical company. The main outcome of his presentation was a statement of readiness for cooperation: the project is open to interaction with developers from Russia, Belarus, and Kazakhstan, as was clearly demonstrated at the conference. Afterwards, Terra Dai (Vice Director of Shanghai Clinical Research Center Project Management Department) gave a report entitled "Pharmaceutical Developments of China on the Global Market: Opportunities and Challenges of International Cooperation in Medical Technologies with SCO Countries."
In his report "Synergy of the Contract Manufacturing Organization and Laboratory in a Central Contract Research Laboratory," Murtazali Dibirov (project coordinator for the SCO) highlighted key problems of localizing clinical research. He noted that it is difficult for manufacturers alone to enter international markets and adapt research to local conditions. The speaker stressed the importance of taking cultural differences into account when working with foreign partners and cited the successful hub model for Central Asia in Uzbekistan. He also focused on problems of laboratory research, pointing out the need for their localization and the creation of a unified quality management system.
Svetlana Beschastnova (GEN Pharma Rus LLC) and Natalia Rosa (CEO, Touch Media Marketing Business Platform for Content Solutions) raised the issue of low patient awareness of clinical research in their joint report. They presented data according to which 60% of patients do not understand what clinical research is, and 80% would like to receive more information. The speakers emphasized that to increase transparency, the communication approach needs to change, overcoming limitations in digital promotion and the lack of quality content. As a successful solution, they presented a case study on promoting dietary supplements through a content factory, which demonstrated the effectiveness of synergy between researchers, marketers, and manufacturers to increase trust and audience reach.
Summing up the section, experts noted that the regulation of pharmacy activities in Russia is undergoing significant changes aimed at integrating pharmacies into a unified healthcare system. Among the key topics for discussion were the problem of standardizing research in the field of traditional medicine and the ethics of conducting such research, as well as the possibilities of creating combination drugs for clinical needs.
As a global trend, participants highlighted the shift from globalization processes to isolation policies in the medical field. According to the speakers, this process inevitably leads to an increased need for international standardization and the search for new formats of cooperation between countries and scientific organizations to ensure the accessibility and quality of medical care.
Sergey Simeniv spoke about how the Russian pharmaceutical industry is adapting to new realities, successfully transitioning to EAEU standards and continuing to develop despite sanctions. According to him, the key to success is an individual approach to each company's tasks, from production to obtaining data.
A large‑scale project in China, where a municipality and a leading medical university are creating a powerful center for clinical research, was presented by Murtazali Dibirov (project coordinator for the SCO). He emphasized that the ecosystem includes technology parks, startups, and the country's second largest pharmaceutical company. The main outcome of his presentation was a statement of readiness for cooperation: the project is open to interaction with developers from Russia, Belarus, and Kazakhstan, as was clearly demonstrated at the conference. Afterwards, Terra Dai (Vice Director of Shanghai Clinical Research Center Project Management Department) gave a report entitled "Pharmaceutical Developments of China on the Global Market: Opportunities and Challenges of International Cooperation in Medical Technologies with SCO Countries."
In his report "Synergy of the Contract Manufacturing Organization and Laboratory in a Central Contract Research Laboratory," Murtazali Dibirov (project coordinator for the SCO) highlighted key problems of localizing clinical research. He noted that it is difficult for manufacturers alone to enter international markets and adapt research to local conditions. The speaker stressed the importance of taking cultural differences into account when working with foreign partners and cited the successful hub model for Central Asia in Uzbekistan. He also focused on problems of laboratory research, pointing out the need for their localization and the creation of a unified quality management system.
Svetlana Beschastnova (GEN Pharma Rus LLC) and Natalia Rosa (CEO, Touch Media Marketing Business Platform for Content Solutions) raised the issue of low patient awareness of clinical research in their joint report. They presented data according to which 60% of patients do not understand what clinical research is, and 80% would like to receive more information. The speakers emphasized that to increase transparency, the communication approach needs to change, overcoming limitations in digital promotion and the lack of quality content. As a successful solution, they presented a case study on promoting dietary supplements through a content factory, which demonstrated the effectiveness of synergy between researchers, marketers, and manufacturers to increase trust and audience reach.
Summing up the section, experts noted that the regulation of pharmacy activities in Russia is undergoing significant changes aimed at integrating pharmacies into a unified healthcare system. Among the key topics for discussion were the problem of standardizing research in the field of traditional medicine and the ethics of conducting such research, as well as the possibilities of creating combination drugs for clinical needs.
As a global trend, participants highlighted the shift from globalization processes to isolation policies in the medical field. According to the speakers, this process inevitably leads to an increased need for international standardization and the search for new formats of cooperation between countries and scientific organizations to ensure the accessibility and quality of medical care.